Yu XQ - Search Results

1

Diverse Role of TGF-β in Kidney Disease.

Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY. Gu YY, et al. Among authors: yu xq. Front Cell Dev Biol. 2020 Feb 28;8:123. doi: 10.3389/fcell.2020.00123. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32258028 Free PMC article. Review.

2

TGF-β in renal fibrosis: triumphs and challenges.

Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY. Gu YY, et al. Among authors: yu xq. Future Med Chem. 2020 May;12(9):853-866. doi: 10.4155/fmc-2020-0005. Epub 2020 Apr 1. Future Med Chem. 2020. PMID: 32233802 Review.

3

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease.

Gu YY, Lu FH, Huang XR, Zhang L, Mao W, Yu XQ, Liu XS, Lan HY. Gu YY, et al. Among authors: yu xq. Front Pharmacol. 2021 Jan 26;11:583528. doi: 10.3389/fphar.2020.583528. eCollection 2020. Front Pharmacol. 2021. PMID: 33574750 Free PMC article. Review.

4

MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis.

Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY. Yu JW, et al. Among authors: yu xq. Lab Invest. 2014 Sep;94(9):978-90. doi: 10.1038/labinvest.2014.91. Epub 2014 Jul 21. Lab Invest. 2014. PMID: 25046436 Free article.

5

Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy.

Ni J, Yang F, Huang XR, Meng J, Chen J, Bader M, Penninger JM, Fung E, Yu XQ, Lan HY. Ni J, et al. Among authors: yu xq. J Cell Mol Med. 2020 Nov;24(22):13093-13103. doi: 10.1111/jcmm.15914. Epub 2020 Sep 24. J Cell Mol Med. 2020. PMID: 32971570 Free PMC article.

6

Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin.

Lian GY, Wang QM, Mak TS, Huang XR, Yu XQ, Lan HY. Lian GY, et al. Among authors: yu xq. Mol Ther Oncolytics. 2021 Jan 20;20:277-289. doi: 10.1016/j.omto.2021.01.006. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33614911 Free PMC article.

7

Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.

Lian GY, Wan Y, Mak TS, Wang QM, Zhang J, Chen J, Wang ZY, Li M, Tang PM, Huang XR, Lee CS, Yu XQ, Lan HY. Lian GY, et al. Among authors: yu xq. Biomaterials. 2022 Sep;288:121730. doi: 10.1016/j.biomaterials.2022.121730. Epub 2022 Aug 12. Biomaterials. 2022. PMID: 35995622 Free article.

8

Current pattern of Chinese dialysis units: a cohort study in a representative sample of units.

Zhou QG, Jiang JP, Wu SJ, Tian JW, Chen JH, Yu XQ, Chen PY, Mei CL, Xiong F, Shi W, Zhou W, Liu XS, Sun SR, Xie D, Liu J, Xu X, Hou FF. Zhou QG, et al. Among authors: yu xq. Chin Med J (Engl). 2012 Oct;125(19):3434-9. Chin Med J (Engl). 2012. PMID: 23044302

9

Long non-coding RNAs as novel diagnostic and therapeutic targets in kidney disease.

Zhou Q, Chen W, Yu XQ. Zhou Q, et al. Among authors: yu xq. Chronic Dis Transl Med. 2020 Jan 8;5(4):252-257. doi: 10.1016/j.cdtm.2019.12.004. eCollection 2019 Dec. Chronic Dis Transl Med. 2020. PMID: 32055784 Free PMC article. Review.

10

[The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].

Dou XR, Yu XQ, Li XY, Chen WF, Hao WK, Jia ZJ, Peng WX, Wang X, Yin PD, Wang WJ, Zheng ZH. Dou XR, et al. Among authors: yu xq. Zhonghua Yi Xue Za Zhi. 2005 Sep 28;85(37):2613-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16321321 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

901 results

Search Page

Filters